key: cord-0761498-izkonns0 authors: Beran, Azizullah; Zink, Evan; Mhanna, Mohammed; Abugharbyeh, Aya; Hanrahan, Jennifer; Duggan, Joan; Assaly, Ragheb title: Transmissibility and viral replication of SARS‐COV‐2 in immunocompromised patients date: 2021-04-03 journal: J Med Virol DOI: 10.1002/jmv.26970 sha: 1c06c1245cdfadc791b86d7b6fc87b646ca4c5d7 doc_id: 761498 cord_uid: izkonns0 Most of the available data are for the immunocompetent population, and the duration of live-virus shedding and transmissibility is well-understood in this population. However, the date regarding infectiousness and shedding of SARS-CoV-2 in the immunocompromised patients is scarce, with no specific guidelines regarding the isolation precautions of these patients. We summarized the findings of all the available studies published until now regarding transmissibility and replication of SARS-CoV-2 in immunosuppressed patients. Studies that reported data regarding viral shedding and replication from respiratory samples (oropharynx or nasopharynx) in immunosuppressed adults with COVID-19 were included. A total of 21 studies, including 69 patients (mean age 52.2 years, and 62.3% males) were included. All patients had persistently positive RT-PCR for > 3 weeks, with median duration of 50.5 days (Interquartile range [IQR] 35-74 days. Five studies[3-7] (including nine patients) reported positive viral cultures with median time of 26 days (IQR 19-94.5). Two studies[7, 8] (including eight patients) reported detecting sub-genomic RNA (sg-RNA) with median duration of 59 days (IQR 29-78). Our review emphasizes the prolonged RT-PCR positivity and viral replication of SAR-CoV-2 in the immunosuppressed population. Our review highlights the importance of close follow-up and prolonged isolation precautions in immunosuppressed patients with persistently positive SARS-CoV-2 RT-PCR. Since viral culture may not be readily available, it may be reasonable to employ sg-RNA as an additional tool for detecting the infectious virus. Further studies with larger sample sizes are needed to evaluate the SARS-CoV-2 shedding and sg-RNA correlation to viral cultures in immunocompromised patients. This article is protected by copyright. All rights reserved. To the Editor, It is known that reverse-transcriptase polymerase chain reaction (RT-PCR) can remain positive for a longer duration in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection as it cannot differentiate between dead and viable virus. 1 The current guidelines from the Centers for Disease Control and Prevention (CDC) suggest that positive RT-PCR beyond 2 weeks is of unclear significance and recommends isolation for 10 days from symptom onset in coronavirus disease 2019 (COVID-19) and up to 20 days in severe cases. 2 Most of the available data are for the immunocompetent population, and the duration of live-virus shedding and transmissibility is well-understood in this population. 3 However, the data regarding infectiousness and shedding of SARS-CoV-2 in the immunocompromised patients is scarce, with no specific guidelines regarding the isolation precautions of these patients. This review aims to summarize the findings of all the available studies in the English language published until now regarding transmissibility and replication of SARS-CoV-2 in immunosuppressed patients. We conducted a comprehensive search of electronic databases through January 05, 2021, for all studies that evaluated viral shedding and replication from respiratory samples (oropharynx or nasopharynx) in immunosuppressed adults with COVID-19. Descriptive statistics were performed to analyze the included studies. A total of 21 studies, including 69 patients (mean age, 52.2 years; 62.3% males), were included (Table 1) . Hematological malignancies were the most prevalent etiology of immunosuppression (66.7%), followed by organ transplants (27.5%). All patients were followed with subsequent RT-PCR tests. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and metaanalysis Centres for Disease Control and Prevention. Duration of isolation and precautions for adults with COVID-19 Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer Prolonged severe acute respiratory syndrome coronavirus 2 replication in an immunocompromised patient Persistence and evolution of SARS-CoV-2 in an immunocompromised host Prolonged SARS-CoV-2 shedding and mild course of COVID-19 in a patient after recent heart transplantation Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer Inference of active viral replication in cases with sustained positive RT-PCRs for SARS-CoV-2 Coronavirus disease 2019 pneumonia in immunosuppressed renal transplant recipients: a summary of 10 confirmed cases in Wuhan, China Duration of SARS-CoV-2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID-19 Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset SARS-CoV-2 virus culture and subgenomic RNA for respiratory specimens from patients with mild coronavirus disease Prolonged severe acute respiratory syndrome coronavirus 2 replication in an immunocompromised patient Persistence and evolution of SARS-CoV-2 in an immunocompromised host Prolonged SARS-CoV-2 shedding and mild course of COVID-19 in a patient after recent heart transplantation